Liberty Wealth Management LLC Novo Nordisk A S Transaction History

Liberty Wealth Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$102.11 - $135.92 $183,491 - $244,248	1,797 New	1,797 $231,000
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $56,665 - $69,194	-591 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $42,463 - $53,629	503 Added 571.59%	591 $62,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $495,474 - $620,697	-7,323 Reduced 98.81%	88 $7,000
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $493,715 - $618,493	7,297 Added 6400.88%	7,411 $88,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $4,791 - $5,535	75 Added 192.31%	114 $8,000
Q3 2020 Nov 05, 2020	SELL	$63.69 - $70.22 $573 - $631	-9 Reduced 18.75%	39 $3,000
Q2 2020 Aug 04, 2020	SELL	$58.54 - $67.94 $117 - $135	-2 Reduced 4.0%	48 $3,000
Q1 2020 Apr 27, 2020	BUY	$49.46 - $64.78 $544 - $712	11 Added 28.21%	50 $3,000
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $9,622 - $11,244	-193 Reduced 83.19%	39 $2,000
Q3 2019 Oct 30, 2019	BUY	$47.54 - $53.43 $1,663 - $1,870	35 Added 17.77%	232 $12,000
Q2 2019 Jul 30, 2019	SELL	$46.79 - $52.47 $11,884 - $13,327	-254 Reduced 56.32%	197 $10,000
Q4 2018 Mar 26, 2019	BUY	$41.54 - $47.25 $18,734 - $21,309	451 New	451 $20,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.